ConnectiveRx Investor Relations Salaries in Bridgeport, CT | Comparably
ConnectiveRx Claimed Company
At ConnectiveRx we take the pain out of the prescription process. We don’t treat patients and we don’t make the medications that do. We use both innovation and human empathy to cut through mountains of red tape and create access to specialty medications for patients who have chronic disease—taking a process that can be expensive and difficult and making it as painless as possible. As one single partner, we connect patients with prescribed medications through hub services, affordability, awareness, and adherence solutions. The result? Happier patients who have a stronger connection to their medication brand. We've done this for hundreds of pharma companies and more than 530 drug brands. Let us facilitate great patient-to-drug experiences that make you shine. read more
EMPLOYEE
PARTICIPANTS
15
TOTAL
RATINGS
144
HR or Marketing? Claim Your Free Employer Account

ConnectiveRx Investor Relations Salaries in Bridgeport, CT

The average ConnectiveRx Investor Relations in Bridgeport, CT earns an estimated $84,936 annually. ConnectiveRx's Investor Relations compensation is $3,006 more than the US average for a Investor Relations.

In Bridgeport, CT, The Communications Department at ConnectiveRx earns $16,737 more on average than the Customer Support Department.

Last updated 6 months ago.

$35k
$47k
$63k
$70k
$109k
$139k
$168k
$84,936
Average Compensation
$84,936
avg. base

Investor Relations Salaries at ConnectiveRx

In Bridgeport, CT, Investor Relations earn $4,977 more than Editors.

Editor
$80k*
* estimated salary

Compensation at ConnectiveRx by Department

In Bridgeport, CT, The Communications Department averages $16,737 more than the Customer Support Department, and $2,697 less than the Finance Department

Finance
$79,991 Avg. total comp.
+$3k
Communications
$77,294 Avg. total comp.
Customer Support
$60,557 Avg. total comp.
-$17k

How Investor Relations at ConnectiveRx Rate Their Compensation

The majority of Investor Relations at ConnectiveRx believe they're not compensated fairly. The vast majority (83%) of Investor Relations at ConnectiveRx are satisfied with their benefits. See more compensation ratings at ConnectiveRx

×
Rate your company